Overall response to anti-IL5/anti-IL5Ra treatment in severe asthma does not depend on initial bronchodilator responsiveness

C. Mümmler (München, Germany), H. Suhling (Hannover, Germany), N. Kneidinger (München, Germany), R. Buhl (Mainz, Germany), M. Kayser (Hannover, Germany), N. Drick (Hannover, Germany), J. Behr (München, Germany), T. Welte (Hannover, Germany), S. Korn (Mainz, Germany), K. Milger (München, Germany)

Source: International Congress 2022 – Allergy and asthma: biomarkers, phenotypes and real-world evidence

Session: Allergy and asthma: biomarkers, phenotypes and real-world evidence
Session type: Thematic Poster
Number: 1687

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Mümmler (München, Germany), H. Suhling (Hannover, Germany), N. Kneidinger (München, Germany), R. Buhl (Mainz, Germany), M. Kayser (Hannover, Germany), N. Drick (Hannover, Germany), J. Behr (München, Germany), T. Welte (Hannover, Germany), S. Korn (Mainz, Germany), K. Milger (München, Germany). Overall response to anti-IL5/anti-IL5Ra treatment in severe asthma does not depend on initial bronchodilator responsiveness. 1687

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.